CAVE CREEK, AZ--(Marketwired - Nov 10, 2016) - Endexx Corporation (OTC PINK: EDXC), a solutions provider of innovative Dispensing and Vending technology solutions, is pleased to announce they will be unveiling their newest technology (the M3Hub Endpoint Inventory Management Vending Solution) at the Pharmacy Technology, Services and Automation EPPS Conference from November 13-15, 2016 at the Hilton Palacio del Rio in San Antonio, TX.
The conference brings together vendors of pharmacy technology and services with retailers, pharmacies, and hospitals to discuss new and expanded offerings. The goal of the conference is to improve the business of pharmacy operations and patient services. In preparation and anticipation of rising state proposals, Endexx's M3Hub has advanced into a managed cloud platform to harness connected devices easily and securely interact with cloud solutions and other point-of-sale(POS) devices.
Endexx CEO, Todd Davis and his team, will meet with industry leaders to demonstrate the recently upgraded technology platform for AutoSpense™ and its benefits to the industry. AutoSpense™ is an industrial grade automated inventory control and dispensing solution for commercial and retail enterprises. The M3Hub "End of Sale" solution improves profitability, accountability, security and customer satisfaction. The AutoSpense™ can be securely installed in a pharmacy, physician's office, hospital, medical clinics and other Caregiving institutions. M3Hub makes it easy for the AutoSpense™ Endpoint Solution to seamlessly integrate into services like, secure, durable, highly-scalable cloud storage, machine learning technologies, fast and flexible database services for all websites & applications, monitoring and compliance services for all resources and the applications throughout the AutoSpense™ Endpoint Solution.
Todd Davis, CEO of Endexx, stated, "This is a high impact event with scheduled private meetings with forty plus distinguished companies in discussing possible collaborations, as well as, providing visibility for our solutions. Our technology has proven to be robust enough to support the industry's needs and we are excited to be unveiling our latest technology and support team."
Endexx provides innovative inventory management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. The company has two technology products and services that launched in 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and an "End of Sale" technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense™ is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites include: www.cbdunlimited.com, www.endexx.com, www.m3hub.com.
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.